Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the effectiveness and safety of risperidone versus haloperidol in patients with chronic schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorder
• Schizophrenia

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Janssen, LP | Conditions: Schizophrenia, Psychotic Disorder | Phase 3 | Status: COMPLETED